Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 89
1982 184
1983 234
1984 226
1985 229
1986 225
1987 298
1988 316
1989 343
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2,144 results
Results by year
Filters applied: . Clear all
Page 1
Safety of ondansetron.
Smith RN. Smith RN. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S47-50; discussion S51-4. Eur J Cancer Clin Oncol. 1989. PMID: 2533899 Review.
Evaluation of fever in the patient with cancer.
Pizzo PA. Pizzo PA. Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S9-16. Eur J Cancer Clin Oncol. 1989. PMID: 2693112 Review.
The clinical pharmacology of ondansetron.
Blackwell CP, Harding SM. Blackwell CP, et al. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S21-4; discussion S25-7. Eur J Cancer Clin Oncol. 1989. PMID: 2533895 Review.
After Goldie-Coldman--where now?
Green JA. Green JA. Eur J Cancer Clin Oncol. 1989 May;25(5):913-6. doi: 10.1016/0277-5379(89)90142-9. Eur J Cancer Clin Oncol. 1989. PMID: 2661241 Review. No abstract available.
Multiple primary cancers of the breast, endometrium and ovary.
Ewertz M, Storm HH. Ewertz M, et al. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1927-32. doi: 10.1016/0277-5379(89)90374-x. Eur J Cancer Clin Oncol. 1989. PMID: 2698808 Review.
Pharmacological and anti-emetic properties of ondansetron.
Tyers MB, Bunce KT, Humphrey PP. Tyers MB, et al. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S15-9. Eur J Cancer Clin Oncol. 1989. PMID: 2533894 Review.
The metabolism of ondansetron.
Saynor DA, Dixon CM. Saynor DA, et al. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S75-7. Eur J Cancer Clin Oncol. 1989. PMID: 2533904
An outline of anti-emetic treatment.
Gralla RJ. Gralla RJ. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S7-11; discussion S13-4. Eur J Cancer Clin Oncol. 1989. PMID: 2696642 Review.
2,144 results
Jump to page
Feedback